hERG1 channel expression associates with molecular subtypes and prognosis in breast cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
hERG1 channel expression associates with molecular subtypes and prognosis in breast cancer
Authors
Keywords
hERG1, Potassium channels, Breast cancer, Molecular subtype, Immunohistochemistry
Journal
Cancer Cell International
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-07-05
DOI
10.1186/s12935-018-0592-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progression
- (2017) Andrea Becchetti et al. Science Signaling
- Preclinical study of a Kv11.1 potassium channel activator as antineoplastic approach for breast cancer
- (2017) Daniela F. Fukushiro-Lopes et al. Oncotarget
- The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progression
- (2017) Andrea Becchetti et al. Science Signaling
- 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
- (2016) Fatima Cardoso et al. NEW ENGLAND JOURNAL OF MEDICINE
- hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy
- (2016) Leonardo Muratori et al. OncoTargets and Therapy
- Current Management Strategies in Breast Cancer by Targeting Key Altered Molecular Players
- (2016) Shazia Ali et al. Frontiers in Oncology
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- (2015) A. S. Coates et al. ANNALS OF ONCOLOGY
- Ion channel expression as promising cancer biomarker
- (2015) Elena Lastraioli et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Minimizing Errors in Breast Pathology: A Call for Action
- (2015) Shahla Masood Breast Journal
- hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma
- (2015) E Lastraioli et al. BRITISH JOURNAL OF CANCER
- Novel perspectives in cancer therapy: Targeting ion channels
- (2015) Annarosa Arcangeli et al. DRUG RESISTANCE UPDATES
- A basal stem cell signature identifies aggressive prostate cancer phenotypes
- (2015) Bryan A. Smith et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- hERG1/Kv11.1 activation stimulates transcription of p21waf/cip in breast cancer cells via a calcineurin-dependent mechanism
- (2015) Mathew Perez-Neut et al. Oncotarget
- Expression of stemness genes in primary breast cancer tissues: the role of SOX2 as a prognostic marker for detection of early recurrence
- (2015) Mauro Finicelli et al. Oncotarget
- European cancer mortality predictions for the year 2014
- (2014) M. Malvezzi et al. ANNALS OF ONCOLOGY
- hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications
- (2014) O. Crociani et al. CLINICAL CANCER RESEARCH
- hERG1 Channels and Glut-1 as Independent Prognostic Indicators of Worse Outcome in Stage I and II Colorectal Cancer: A Pilot Study
- (2014) Elena Lastraioli et al. Translational Oncology
- Breast cancer statistics, 2013
- (2013) Carol DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
- (2013) H. Masuda et al. CLINICAL CANCER RESEARCH
- The Omics of Triple-Negative Breast Cancers
- (2013) H. Xu et al. CLINICAL CHEMISTRY
- The requirements of a specialist Breast Centre
- (2013) A.R.M. Wilson et al. EUROPEAN JOURNAL OF CANCER
- Expression profiling of ion channel genes predicts clinical outcome in breast cancer
- (2013) Jae-Hong Ko et al. Molecular Cancer
- Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
- (2013) Irène Baccelli et al. NATURE BIOTECHNOLOGY
- Potassium Channels: Novel Emerging Biomarkers and Targets for Therapy in Cancer
- (2013) Massimo D’Amico et al. Recent Patents on Anti-Cancer Drug Discovery
- Potassium channel activation inhibits proliferation of breast cancer cells by activating a senescence program
- (2013) K Lansu et al. Cell Death & Disease
- hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer
- (2013) Olivia Crociani et al. Scientific Reports
- The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality
- (2012) Danny R. Youlden et al. Cancer Epidemiology
- Global cancer transitions according to the Human Development Index (2008–2030): a population-based study
- (2012) Freddie Bray et al. LANCET ONCOLOGY
- Role of KCNMA1 in Breast Cancer
- (2012) Martin Oeggerli et al. PLoS One
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of KCNMA1gene in breast cancer invasion and metastasis to brain
- (2009) Divya Khaitan et al. BMC CANCER
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started